World Journal of Hepatology - Baishideng Publishing Group

Advanced Search

BPG is committed to discovery and dissemination of knowledge

JOURNAL HOME

Number of total visits: 7238232

Number of visits today: 718

Number of downloads: 4733165

PUBLISHING PARTNER

INDEXING/ABSTRACTING

MEMBERSHIP

BPG JOURNAL LIST

Open-Access Journal

Other Issues: Previous | Next | Latest | Archive | Download full issue 3 (834)

Contents Volume 2 Issue 3 March 27, 2010

Editorial

Effect of antiviral treatment on the risk of hepatocellular carcinoma in patients with chronic hepatitis B

Konstantinos Tziomalos

World J Hepatol 2(3):91-93. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.91

Abstract (1232) | Core Tip (845) | Full Article (HTML) (2498) | Full Article (PDF)-515K (331) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (6) | Total Visits (5051) | Similar Articles (2024) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Guidelines for Basic Science

Interactions of chemical carcinogens and genetic variation in hepatocellular carcinoma

Yu-Jing Zhang

World J Hepatol 2(3):94-102. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.94

Abstract (1236) | Core Tip (925) | Full Article (HTML) (3928) | Full Article (PDF)-707K (395) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (27) | Total Visits (6633) | Similar Articles (1846) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Guidelines for Clinical Practice

Medical treatment of unresectable hepatocellular carcinoma: Going beyond sorafenib

Camillo Porta, Chiara Paglino

World J Hepatol 2(3):103-113. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.103

Abstract (1204) | Core Tip (891) | Full Article (HTML) (3033) | Figures (1-2) (481) | Tables (1-3) (469) | Full Article (PDF)-857K (356) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (11) | Total Visits (6628) | Similar Articles (1846) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Review

Hepatic cancer stem cells and drug resistance: Relevance in targeted therapies for hepatocellular carcinoma

Caecilia HC Sukowati, Natalia Rosso, Lory S Crocè, Claudio Tiribelli

World J Hepatol 2(3):114-126. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.114

Abstract (1309) | Core Tip (878) | Full Article (HTML) (8080) | Figures (1-3) (474) | Tables (1-2) (582) | Full Article (PDF)-880K (641) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (39) | Total Visits (12160) | Similar Articles (1918) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Brief Article

Proteomic analysis for developing new biomarkers of hepatocellular carcinoma

Maria Pleguezuelo, Laura M Lopez-Sanchez, Antonio Rodriguez-Ariza, Jose L Montero, Javier Briceno, Ruben Ciria, Jordi Muntane, Manuel de la Mata

World J Hepatol 2(3):127-135. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.127

Abstract (1312) | Core Tip (866) | Full Article (HTML) (4489) | Figures (1-4) (434) | Tables (1-2) (494) | Full Article (PDF)-862K (596) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (12) | Total Visits (8362) | Similar Articles (0) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Case Report

Granulocyte colony-stimulating factor as a novel adjunct to improve hepatitis B vaccination

Sudeep Tanwar, Mark Thursz

World J Hepatol 2(3):136-138. Published online Mar 27, 2010. doi: 10.4254/wjh.v2.i3.136

Abstract (1491) | Core Tip (904) | Full Article (HTML) (2664) | Full Article (PDF)-510K (297) | RCA | PubMed Central | PubMed | CrossRef | Google Scholar | Times Cited (2) | Total Visits (5509) | Similar Articles (236) | Article Quality Tracking (0) | What about the content of this article? (0) | Cite |

(0) | Open

Write to the Help Desk

© 1993-2026 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

California Corporate Number: 3537345